Related Experiment Video
Updated: Mar 16, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Chronic Heart Failure
1Division of Cardiology, Department of Pediatrics, University of North Carolina School of Medicine, University of North Carolina Children's Hospital, Chapel Hill, NC.
Insights
This review discusses pediatric heart failure staging, cardiomyopathies, and pharmacologic management. It highlights the need for pediatric-specific approaches over adult trial extrapolation for better treatment outcomes in children.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Medicine
- Pharmacology
Background:
- The causes of chronic heart failure in children are diverse.
- Extrapolating adult treatment guidelines to pediatric heart failure is unsustainable.
- Pediatric heart failure management requires specialized approaches.
Purpose of the Study:
- To review current paradigms for staging heart failure in children.
- To discuss the classification and physiological profiles of cardiomyopathies.
- To outline acute and chronic pharmacologic management strategies for pediatric heart failure.
Main Methods:
- Literature review of MEDLINE and PubMed databases.
- Analysis of existing paradigms in pediatric heart failure staging and management.
- Synthesis of information on cardiomyopathies and pharmacologic treatments.
Main Results:
- Current adult-centric models are inadequate for pediatric heart failure.
- There is a growing need for pediatric-specific descriptors and databases.
- Advancements in guideline-directed care and international collaboration are crucial.
Conclusions:
- Pediatric heart failure management is evolving with a focus on guideline-directed care.
- A dynamic international database is needed for robust research.
- Integrating pediatric heart failure and critical care medicine will optimize patient therapy.
Objectives:
The objectives of this review are to discuss the paradigms used to stage heart failure in children, the classification and physiologic profile of cardiomyopathies, and the acute and chronic pharmacologic management of heart failure.
Data Source:
MEDLINE, PubMed.
Conclusion:
The etiology of chronic heart failure in pediatrics is vast. The paradigm of extrapolating adult clinical trials and technological advancements to treat heart failure in children has become a nonsustainable model. The field of pediatric heart failure continues to advance with more robust guideline-directed care and the imminent creation of a dynamic, contemporary international database. As the field involves a markedly heterogeneous patient population, it is imperative to use pediatric specific descriptors of disease impact. The fields of pediatric heart failure and critical care medicine will continue to evolve together as childhood specific registries, quality improvement guidelines, and research will lead to practice models eliciting optimal therapy for patients with heart failure in the intensive care setting.
Related Concept Videos
Heart Failure I: Introduction
Pathophysiology of Heart Failure
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure III: Clinical Manifestations
Heart Failure VII: Nursing Interventions

